Stocktoria
Baird Medical Investment Holdings Ltd BDMD
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-13
Baird Medical Investment Holdings Ltd financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $22.5M | $37.0M | $31.5M |
| Gross profit | $18.9M | $32.7M | $27.2M |
| R&D expense | $20.1M | $6.2M | $4.3M |
| Operating income | -$25.6M | $15.3M | $11.9M |
| Income tax | $1.2M | $1.5M | $1.7M |
| Net income | -$27.3M | $12.5M | $10.5M |
| EPS (diluted) | $-0.98 | $0.57 | $0.51 |
| Operating cash flow | -$1.3M | -$6.3M | -$1.0M |
| Free cash flow | -$1.4M | -$9.2M | -$3.7M |
| Cash & equivalents | $178,321 | $3.0M | — |
| Inventory | $1.1M | $1.3M | $1.1M |
| Total assets | $69.7M | $78.0M | $56.7M |
| Total liabilities | $38.5M | $38.2M | $21.0M |
| Shareholders' equity | $31.4M | $39.8M | $35.8M |
Growth · year-over-year · Revenue CAGR -15.4%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | -39.2% | +17.7% | — |
| Net income growth | -319.0% | +18.1% | — |
| EPS growth | -271.9% | +11.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.